https://www.selleckchem.com/products/azd2014.html
Aim Describe the safety and effectiveness of intra-articular bone marrow concentrate (BMC) injection to treat knee and/or hip osteoarthritis (OA) in a Canadian cohort. Materials methods A total of 112 patients with refractory OA received a single intra-articular injection of BMC into their knee(s) and/or hip(s). Pain, disability and quality of life were prospectively assessed prior to and 3, 6 and 12 months post-injection. Results Outcome scores were significantly improved at all time points post-BMC injection with maximal improve
Like
Comment
Share
